Please provide your email address to receive an email when new articles are posted on . 52-week study included 85 adults with Parkinson’s and at least 3 hours/day of “off” time. At week 12, CSAI led ...
Bial, an innovation-driven biopharmaceutical company, today announced the launch of KYNMOBI ® (apomorphine hydrochloride) in the United Kingdom, the first sublingual film indicated for the ...
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback